Home › Trial NCT01216826
Phase II Study of Everolimus in Children and Adolescents With Refractory or Relapsed Osteosarcoma
- Trial IDNCT01216826
- StatusUnknown
- PhasePhase 2
- Study typeInterventional
- SponsorSidnei Epelman
- Enrollment20
- Start date2011-03
- ConditionsRefractory or Relapsed Osteosarcoma
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.